PL2850100T3 - Rekombinowana bakteryjna komórka gospodarz do ekspresji białka - Google Patents

Rekombinowana bakteryjna komórka gospodarz do ekspresji białka

Info

Publication number
PL2850100T3
PL2850100T3 PL13723086T PL13723086T PL2850100T3 PL 2850100 T3 PL2850100 T3 PL 2850100T3 PL 13723086 T PL13723086 T PL 13723086T PL 13723086 T PL13723086 T PL 13723086T PL 2850100 T3 PL2850100 T3 PL 2850100T3
Authority
PL
Poland
Prior art keywords
host cell
protein expression
bacterial host
recombinant bacterial
recombinant
Prior art date
Application number
PL13723086T
Other languages
English (en)
Inventor
Philip Jonathan Bassett
David Paul Humphreys
Pareshkumar Manjibhai PATEL
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of PL2850100T3 publication Critical patent/PL2850100T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
PL13723086T 2012-05-14 2013-05-13 Rekombinowana bakteryjna komórka gospodarz do ekspresji białka PL2850100T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201208367A GB201208367D0 (en) 2012-05-14 2012-05-14 Biological product
PCT/EP2013/059803 WO2013171156A1 (en) 2012-05-14 2013-05-13 Recombinant bacterial host cell for protein expression
EP13723086.8A EP2850100B1 (en) 2012-05-14 2013-05-13 Recombinant bacterial host cell for protein expression

Publications (1)

Publication Number Publication Date
PL2850100T3 true PL2850100T3 (pl) 2019-04-30

Family

ID=46458730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13723086T PL2850100T3 (pl) 2012-05-14 2013-05-13 Rekombinowana bakteryjna komórka gospodarz do ekspresji białka

Country Status (30)

Country Link
US (2) US9951365B2 (pl)
EP (1) EP2850100B1 (pl)
JP (2) JP6420759B2 (pl)
KR (1) KR102036399B1 (pl)
CN (2) CN104487454A (pl)
AU (1) AU2013261915B2 (pl)
BR (1) BR112014027357A2 (pl)
CA (1) CA2872328C (pl)
CL (1) CL2014003112A1 (pl)
CO (1) CO7240426A2 (pl)
CY (1) CY1121192T1 (pl)
DK (1) DK2850100T3 (pl)
EA (1) EA201492100A1 (pl)
ES (1) ES2704425T3 (pl)
GB (1) GB201208367D0 (pl)
HR (1) HRP20190025T1 (pl)
HU (1) HUE040624T2 (pl)
IL (1) IL235041B (pl)
LT (1) LT2850100T (pl)
ME (1) ME03309B (pl)
MX (1) MX353066B (pl)
MY (1) MY166223A (pl)
PL (1) PL2850100T3 (pl)
PT (1) PT2850100T (pl)
RS (1) RS58219B1 (pl)
SG (1) SG11201406474RA (pl)
SI (1) SI2850100T1 (pl)
SM (1) SMT201900011T1 (pl)
TR (1) TR201900073T4 (pl)
WO (1) WO2013171156A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774692C (en) 2009-09-24 2017-12-19 Ucb Pharma S.A. Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
SMT201800068T1 (it) 2011-07-13 2018-03-08 Ucb Biopharma Sprl Ceppo ospite batterico che esprime dsbc ricombinante
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
CA3098910A1 (en) 2018-05-01 2019-11-07 Ambrx, Inc. A method for optimizing antibody expression
CN113260626B (zh) * 2018-11-05 2024-09-13 豪夫迈·罗氏有限公司 在原核宿主细胞中产生双链蛋白质的方法
CN113874518B (zh) * 2019-03-18 2025-04-25 生物辐射Abd瑟罗泰克有限公司 保护含SpyTag的周质融合蛋白免于蛋白酶Tsp和OmpT降解
AU2023281650A1 (en) 2022-05-30 2024-10-17 Hanall Biopharma Co., Ltd. Anti-fcrn antibody or antigen binding fragment thereof with improved stability

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
PT1124941E (pt) 1998-10-28 2004-02-27 Genentech Inc Processo para recuperar polipeptidos heterologos a partir de celulas bacterianas
JP2003503074A (ja) 1999-06-29 2003-01-28 シガ・テクノロジーズ,インコーポレイテッド Degpプロテアーゼインヒビター類の分析方法
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
EP1314037A2 (en) 2000-09-01 2003-05-28 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
EP1356052B1 (en) * 2000-12-14 2008-08-20 Genentech, Inc. Production of full antibodies in procaryotic cells
BR0116680A (pt) 2000-12-14 2005-04-05 Genentech Inc Linhagem de e. coli e método de produção de um polipeptìdeo
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
EP1427744B1 (en) 2001-08-27 2007-12-26 Genentech, Inc. A system for antibody expression and assembly
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
ATE420964T1 (de) 2001-11-16 2009-01-15 Biogen Idec Inc Polycistronische expression von antikörpern in cho zellen
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
CN1678634A (zh) 2002-06-28 2005-10-05 多曼蒂斯有限公司 免疫球蛋白单个变体抗原结合区及其特异性构建体
GB0224082D0 (en) 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
MXPA05004677A (es) 2002-10-31 2005-11-17 Genentech Inc Metodos y composiciones para aumentar la produccion de anticuerpos.
WO2004051268A1 (en) 2002-12-03 2004-06-17 Celltech R & D Limited Assay for identifying antibody producing cells
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
DK1639014T3 (da) 2003-06-13 2011-01-17 Biogen Idec Inc Aglycosyl-anti-CD154 (CD40-ligand)-antistoffer og anvendelser deraf
JP5087274B2 (ja) 2003-06-30 2012-12-05 ドマンティス リミテッド ポリペプチド
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
JP4944608B2 (ja) 2003-07-26 2012-06-06 バイオジェン・アイデック・エムエイ・インコーポレイテッド 改良された抗原結合親和性を有する、変更された抗体
WO2006078273A2 (en) * 2004-04-26 2006-07-27 The United States Of America As Represented By Teh Secretary Of Health And Human Services, Nih Methods and compositions for producing recombinant proteins
AU2005287406B2 (en) 2004-07-26 2011-08-18 Biogen Ma Inc. Anti-CD154 antibodies
WO2006028936A2 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
BRPI0809042B1 (pt) 2007-03-22 2021-08-31 Biogen Ma Inc. Proteína de ligação a cd154 isolada, seu uso, e composição
EP2535350B1 (en) 2007-09-26 2018-01-24 UCB Biopharma SPRL Dual specificity antibody fusions
US10407513B2 (en) 2008-09-26 2019-09-10 Ucb Biopharma Sprl Biological products
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
CA2774692C (en) 2009-09-24 2017-12-19 Ucb Pharma S.A. Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
KR101968766B1 (ko) 2009-11-05 2019-04-12 제넨테크, 인크. 이종 폴리펩티드의 분비를 위한 방법 및 조성물
GB201000587D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
SMT201800068T1 (it) 2011-07-13 2018-03-08 Ucb Biopharma Sprl Ceppo ospite batterico che esprime dsbc ricombinante
EP2546267A1 (en) * 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
MY166223A (en) 2018-06-22
MX353066B (es) 2017-12-19
CN104487454A (zh) 2015-04-01
CO7240426A2 (es) 2015-04-17
LT2850100T (lt) 2019-01-25
US11261470B2 (en) 2022-03-01
WO2013171156A1 (en) 2013-11-21
PT2850100T (pt) 2019-01-21
EA201492100A1 (ru) 2015-02-27
CY1121192T1 (el) 2020-05-29
BR112014027357A2 (pt) 2017-08-08
IL235041A0 (en) 2014-12-31
GB201208367D0 (en) 2012-06-27
SG11201406474RA (en) 2014-11-27
IL235041B (en) 2019-10-31
KR20150014936A (ko) 2015-02-09
CA2872328C (en) 2020-10-13
ME03309B (me) 2019-10-20
JP2015516166A (ja) 2015-06-11
CL2014003112A1 (es) 2015-06-19
CA2872328A1 (en) 2013-11-21
US20180258457A1 (en) 2018-09-13
EP2850100A1 (en) 2015-03-25
HUE040624T2 (hu) 2019-03-28
KR102036399B1 (ko) 2019-10-24
MX2014012623A (es) 2015-01-15
US20150111249A1 (en) 2015-04-23
TR201900073T4 (tr) 2019-01-21
SMT201900011T1 (it) 2019-02-28
EP2850100B1 (en) 2018-10-10
AU2013261915A1 (en) 2014-12-18
JP2018198597A (ja) 2018-12-20
RS58219B1 (sr) 2019-03-29
JP6420759B2 (ja) 2018-11-07
AU2013261915B2 (en) 2017-12-14
CN110591991A (zh) 2019-12-20
ES2704425T3 (es) 2019-03-18
HRP20190025T1 (hr) 2019-02-22
DK2850100T3 (en) 2019-02-04
SI2850100T1 (sl) 2019-02-28
US9951365B2 (en) 2018-04-24

Similar Documents

Publication Publication Date Title
IL235041B (en) Recombinant bacterial host cell for protein expression
IL275270B (en) Recombinant scavenger cell surface proteins
HRP20190454T1 (hr) Rekombinantni faktor viii proteini
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
BR112014024675A8 (pt) célula hospedeira recombinante, cultura celular
IL239285A0 (en) Yogurts with high protein
SG10201500208SA (en) Npp1 fusion proteins
IL237740A0 (en) Recombinant organisms
PL2714888T3 (pl) Rekombinowane drożdże
PT2964775T (pt) Promotores de leveduras para a expressão proteica
ZA201406434B (en) Improved harvest operations for recombinant proteins
PL2714902T3 (pl) Wektory ekspresyjne do polepszonej sekrecji białka
KR20180085063A (ko) 신규 단백질 소재
GB201107468D0 (en) Protein expression systems
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
EP2851083B8 (en) Radiation-sterilization-resistant protein composition
GB201213672D0 (en) Protein
GB201203587D0 (en) Modified bacterial cell
SG11201504096RA (en) Recombinant protein
GB201103169D0 (en) Protein expression
HUP1200080A2 (en) Biotin labeled protein expression system
GB201215901D0 (en) Protein modification
HUP1100282A2 (en) Protein factor
AU2011904284A0 (en) Novel protein
GB201210286D0 (en) Recombinant polypeptide